Activity of Cefiderocol Alone and in Combination with Levofloxacin, Minocycline, Polymyxin B, or Trimethoprim-Sulfamethoxazole against Multidrug-Resistant Stenotrophomonas maltophilia

The production of an L1 metallo-β-lactamase and an L2 serine active-site β-lactamase precludes the use of β-lactams for the treatment of Stenotrophomonas maltophilia infections. Preclinical data suggest that cefiderocol is the first approved β-lactam with reliable activity against S. maltophilia, bu...

Descripción completa

Detalles Bibliográficos
Autores principales: Biagi, M., Vialichka, A., Jurkovic, M., Wu, T., Shajee, A., Lee, M., Patel, S., Mendes, R. E., Wenzler, E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2020
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449157/
https://www.ncbi.nlm.nih.gov/pubmed/32571820
http://dx.doi.org/10.1128/AAC.00559-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449157/
https://www.ncbi.nlm.nih.gov/pubmed/32571820
http://dx.doi.org/10.1128/AAC.00559-20

Ejemplares similares